Perspective Therapeutics Stock Market Value
| CATX Stock | 4.12 0.28 6.36% |
| Symbol | Perspective |
Perspective Therapeutics Price To Book Ratio
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Perspective Therapeutics. If investors know Perspective will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Perspective Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.33) | Revenue Per Share 0.029 | Quarterly Revenue Growth 0.337 | Return On Assets (0.14) | Return On Equity (0.27) |
The market value of Perspective Therapeutics is measured differently than its book value, which is the value of Perspective that is recorded on the company's balance sheet. Investors also form their own opinion of Perspective Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Perspective Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Perspective Therapeutics' market value can be influenced by many factors that don't directly affect Perspective Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Perspective Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Perspective Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Perspective Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Perspective Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Perspective Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Perspective Therapeutics.
| 10/30/2024 |
| 11/29/2024 |
If you would invest 0.00 in Perspective Therapeutics on October 30, 2024 and sell it all today you would earn a total of 0.00 from holding Perspective Therapeutics or generate 0.0% return on investment in Perspective Therapeutics over 30 days. Perspective Therapeutics is related to or competes with Orthopediatrics Corp, Orthofix Medical, Sight Sciences, Neuropace, CVRx, PAVmed, and Hyperfine. Perspective Therapeutics is entity of United States More
Perspective Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Perspective Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Perspective Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.20) | |||
| Maximum Drawdown | 57.58 | |||
| Value At Risk | (11.66) | |||
| Potential Upside | 6.21 |
Perspective Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Perspective Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Perspective Therapeutics' standard deviation. In reality, there are many statistical measures that can use Perspective Therapeutics historical prices to predict the future Perspective Therapeutics' volatility.| Risk Adjusted Performance | (0.13) | |||
| Jensen Alpha | (1.58) | |||
| Total Risk Alpha | (2.78) | |||
| Treynor Ratio | (3.49) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Perspective Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Perspective Therapeutics Backtested Returns
Perspective Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of -0.18, which implies the firm had a -0.18% return per unit of risk over the last 3 months. Perspective Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Perspective Therapeutics' Coefficient Of Variation of (544.77), risk adjusted performance of (0.13), and Variance of 68.77 to confirm the risk estimate we provide. The company holds a Beta of 0.44, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Perspective Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Perspective Therapeutics is expected to be smaller as well. At this point, Perspective Therapeutics has a negative expected return of -1.48%. Please make sure to check Perspective Therapeutics' total risk alpha, kurtosis, as well as the relationship between the Kurtosis and market facilitation index , to decide if Perspective Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.30 |
Below average predictability
Perspective Therapeutics has below average predictability. Overlapping area represents the amount of predictability between Perspective Therapeutics time series from 30th of October 2024 to 14th of November 2024 and 14th of November 2024 to 29th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Perspective Therapeutics price movement. The serial correlation of 0.3 indicates that nearly 30.0% of current Perspective Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.3 | |
| Spearman Rank Test | 0.15 | |
| Residual Average | 0.0 | |
| Price Variance | 3.65 |
Perspective Therapeutics lagged returns against current returns
Autocorrelation, which is Perspective Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Perspective Therapeutics' stock expected returns. We can calculate the autocorrelation of Perspective Therapeutics returns to help us make a trade decision. For example, suppose you find that Perspective Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Perspective Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Perspective Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Perspective Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Perspective Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Perspective Therapeutics Lagged Returns
When evaluating Perspective Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Perspective Therapeutics stock have on its future price. Perspective Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Perspective Therapeutics autocorrelation shows the relationship between Perspective Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Perspective Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Perspective Stock Analysis
When running Perspective Therapeutics' price analysis, check to measure Perspective Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Perspective Therapeutics is operating at the current time. Most of Perspective Therapeutics' value examination focuses on studying past and present price action to predict the probability of Perspective Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Perspective Therapeutics' price. Additionally, you may evaluate how the addition of Perspective Therapeutics to your portfolios can decrease your overall portfolio volatility.